Shopping Cart
Remove All
Your shopping cart is currently empty
Telisotuzumab vedotin
😃Good
Catalog No. T77838Cas No. 1714088-51-3
Alias ABT399, ABT 399, ABBV-399, ABBV399
Telisotuzumab vedotin (ABBV-399) is an ADC compound targeting c-Met with antitumor activity, used for research in recurrent squamous cell lung cancer.
Telisotuzumab vedotin
Telisotuzumab vedotin
😃Good
Purity: 95%
Catalog No. T77838Alias ABT399, ABT 399, ABBV-399, ABBV399Cas No. 1714088-51-3
Telisotuzumab vedotin (ABBV-399) is an ADC compound targeting c-Met with antitumor activity, used for research in recurrent squamous cell lung cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $239 | - | In Stock | |
| 5 mg | $591 | - | In Stock | |
| 10 mg | $977 | - | In Stock | |
| 25 mg | $1,450 | - | In Stock | |
| 50 mg | $1,950 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.5% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Telisotuzumab vedotin (ABBV-399) is an ADC compound targeting c-Met with antitumor activity, used for research in recurrent squamous cell lung cancer. |
| Targets&IC50 | c-Met:0.30 nmol/L (EC50) |
| In vitro | Telisotuzumab vedotin inhibits the proliferation of cancer cells that overexpress c-Met, These included MET-amplified SNU-620, SNU-5, and Hs 746T gastric cancer cells, as well as c-Met overexpressed NCI-H441, EBC-1, and NCI-H820 NSCLC cell lines. [2] |
| In vivo | Telisotuzumab vedotin (1 or 3 mg/kg, once every 4 days, intrperitoneally administered) inhibits the growth of c-Met inhibitor-resistant xenograft tumors. [2] |
| Synonyms | ABT399, ABT 399, ABBV-399, ABBV399 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | MMAE |
| Gene ID | |
| Uniprot ID | |
| Target | HGFR/c-Met |
| Molecular Weight | 151.37 kDa |
| Cas No. | 1714088-51-3 |
| Isotype | IgG1-MMAE |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 80.00 mg/mL, Sonication is recommended. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Telisotuzumab vedotin | purchase Telisotuzumab vedotin | Telisotuzumab vedotin cost | order Telisotuzumab vedotin | Telisotuzumab vedotin in vivo | Telisotuzumab vedotin in vitro | Telisotuzumab vedotin molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.